What is the significance of Bradley E. Lerman's retirement?

Bradley E. Lerman's retirement marks the end of an era for Medtronic's legal leadership. As Senior Vice President, General Counsel, and Corporate Secretary for over seven years, his departure necessitates a succession plan. The company's proactive search for a successor indicates a focus on maintaining stability and continuity in critical legal and corporate governance functions.

Who is Jennifer Kirk and what is her new role?

Jennifer Kirk has been appointed as Medtronic's Principal Accounting Officer, Global Controller, and Chief Accounting Officer. This role consolidates previous functions and follows the retirement of the prior officers. Ms. Kirk, a CPA, has a strong background in accounting and finance, notably serving as Vice President, Controller, and Principal Accounting Officer at Occidental Petroleum.

What are the financial implications of Jennifer Kirk's appointment for investors?

For investors, Ms. Kirk's appointment signifies a move towards streamlined financial oversight with the consolidation of key accounting roles. Her compensation package, including participation in Medtronic's MIP and LTIP, is standard for executive positions and reflects the company's incentive structures. The detailed severance and change-in-control provisions are also important for understanding potential future financial commitments should certain circumstances arise, though they are typical for executive employment agreements.

Are there any immediate concerns for investors regarding these executive changes?

Generally, these changes appear to be part of normal executive succession planning. The company has announced the retirement well in advance and is actively searching for Mr. Lerman's replacement. The appointment of Ms. Kirk, who has relevant experience, suggests a continued focus on robust financial and accounting leadership. Investors may want to monitor the progress of the General Counsel search and the integration of Ms. Kirk into her new role.

MDT 8-K: Leadership Changes

Summary

Medtronic plc (MDT) announced two significant executive changes via an 8-K filing on June 29, 2021, related to events on June 23 and 25, 2021. Senior Vice President, General Counsel and Corporate Secretary, Bradley E. Lerman, will retire effective December 31, 2021, after a distinguished career. The company has initiated a search for his successor, aiming for a seamless transition. In parallel, Jennifer Kirk has been appointed as the new Principal Accounting Officer, Global Controller, and Chief Accounting Officer, effective June 30, 2021. This consolidated role follows the recent retirements of the previous controller and chief accounting officer. Ms. Kirk brings extensive experience from Occidental Petroleum Corporation and Arthur Andersen LLP, including her previous role as Vice President, Controller, and Principal Accounting Officer. Her compensation and severance packages are detailed, aligning with Medtronic's incentive plans and change-in-control policies.

Key Highlights

1Retirement of Senior Vice President, General Counsel and Corporate Secretary, Bradley E. Lerman, effective December 31, 2021.
2Initiation of a search for Mr. Lerman's successor to ensure a smooth leadership transition.
3Appointment of Jennifer Kirk as Principal Accounting Officer, Global Controller, and Chief Accounting Officer, effective June 30, 2021.
4Consolidation of the controller and chief accounting officer roles into a single position under Ms. Kirk.
5Ms. Kirk has significant prior experience, including as Vice President, Controller, and Principal Accounting Officer at Occidental Petroleum.
6Details provided on Ms. Kirk's compensation, including base salary, short-term (MIP), and long-term incentive plans (LTIP), commensurate with her role.
7Ms. Kirk's severance package and change-in-control provisions are outlined, providing a level of executive protection.

Medtronic plc 8-K Report, Executive Changes (Jun 30, 2021)

Summary

Key Highlights

Frequently Asked Questions